data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Innoviva
(NASDAQ:INVA)
$14.89
0.13[0.88%]
At close: Jul 1
$14.89
00
After Hours: 4:01PM EDT
Day High/Low14.61 - 14.98
52 Week High/Low12.91 - 20.71
Open / Close14.72 / 14.89
Float / Outstanding60.3M / 69.7M
Vol / Avg.617.3K / 1M
Mkt Cap1B
P/E6.62
50d Avg. Price15.63
Div / Yield-
Payout Ratio-
EPS0.23
Total Float60.3M

Innoviva (NASDAQ:INVA), Quotes and News Summary

Innoviva (NASDAQ: INVA)

Day High/Low14.61 - 14.98
52 Week High/Low12.91 - 20.71
Open / Close14.72 / 14.89
Float / Outstanding60.3M / 69.7M
Vol / Avg.617.3K / 1M
Mkt Cap1B
P/E6.62
50d Avg. Price15.63
Div / Yield-
Payout Ratio-
EPS0.23
Total Float60.3M
Benzinga - May 23, 2022, 10:04AM
Benzinga - May 23, 2022, 8:38AM
Benzinga - Apr 27, 2022, 5:25PM
Benzinga - Apr 12, 2022, 10:00AM
Benzinga - Mar 15, 2022, 9:14AM
Benzinga - Mar 2, 2022, 7:32AM
Benzinga - Feb 23, 2022, 8:25AM
Benzinga - Feb 11, 2022, 8:38AM
Benzinga - Feb 10, 2022, 6:55AM
Benzinga - Feb 9, 2022, 5:02PM
Benzinga - Feb 2, 2022, 4:35PM
Benzinga - Feb 2, 2022, 6:10AM
Benzinga - Oct 27, 2021, 4:44PM
load more
Sector: Health Care.Industry: Pharmaceuticals
Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. The firm collaborates with and receives funding from GlaxoSmithKline.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-07-27
REV
Q1 2022Est.ActualSurprise
EPS0.4400.390 -0.0500
REV90.500M90.059M-441.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Innoviva Questions & Answers

Q
How do I buy Innoviva (INVA) stock?
A

You can purchase shares of Innoviva (NASDAQ: INVA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Innoviva's (INVA) competitors?
Q
What is the target price for Innoviva (INVA) stock?
A

The latest price target for Innoviva (NASDAQ: INVA) was reported by Morgan Stanley on Tuesday, April 12, 2022. The analyst firm set a price target for 13.00 expecting INVA to fall to within 12 months (a possible -12.69% downside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Innoviva (INVA)?
A

The stock price for Innoviva (NASDAQ: INVA) is $14.89 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Innoviva (INVA) pay a dividend?
A

There are no upcoming dividends for Innoviva.

Q
When is Innoviva (NASDAQ:INVA) reporting earnings?
A

Innoviva’s Q2 earnings are confirmed for Wednesday, July 27, 2022.

Q
Is Innoviva (INVA) going to split?
A

There is no upcoming split for Innoviva.

Q
What sector and industry does Innoviva (INVA) operate in?
A

Innoviva is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.